001     1014969
005     20240311125732.0
024 7 _ |a 10.1016/j.clim.2023.109757
|2 doi
024 7 _ |a 1521-6616
|2 ISSN
024 7 _ |a 1521-7035
|2 ISSN
024 7 _ |a 10.34734/FZJ-2023-03513
|2 datacite_doi
024 7 _ |a 37689091
|2 pmid
024 7 _ |a WOS:001165275000001
|2 WOS
037 _ _ |a FZJ-2023-03513
082 _ _ |a 610
100 1 _ |a Yakici, Nalan
|0 P:(DE-HGF)0
|b 0
245 _ _ |a Expanding the clinical and immunological phenotypes of PAX1-deficient SCID and CID patients
260 _ _ |a Orlando, Fla.
|c 2023
|b Academic Press
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1695379413_3362
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Paired box 1 (PAX1) deficiency has been reported in a small number of patients diagnosed with otofaciocervical syndrome type 2 (OFCS2). We described six new patients who demonstrated variable clinical penetrance. Reduced transcriptional activity of pathogenic variants confirmed partial or complete PAX1 deficiency. Thymic aplasia and hypoplasia were associated with impaired T cell immunity. Corrective treatment was required in 4/6 patients. Hematopoietic stem cell transplantation resulted in poor immune reconstitution with absent naïve T cells, contrasting with the superior recovery of T cell immunity after thymus transplantation. Normal ex vivo differentiation of PAX1-deficient CD34+ cells into mature T cells demonstrated the absence of a hematopoietic cell-intrinsic defect. New overlapping features with DiGeorge syndrome included primary hypoparathyroidism (n = 5) and congenital heart defects (n = 2), in line with PAX1 expression during early embryogenesis. Our results highlight new features of PAX1 deficiency, which are relevant to improving early diagnosis and identifying patients requiring corrective treatment.
536 _ _ |a 5111 - Domain-Specific Simulation & Data Life Cycle Labs (SDLs) and Research Groups (POF4-511)
|0 G:(DE-HGF)POF4-5111
|c POF4-511
|f POF IV
|x 0
536 _ _ |a 2171 - Biological and environmental resources for sustainable use (POF4-217)
|0 G:(DE-HGF)POF4-2171
|c POF4-217
|f POF IV
|x 1
536 _ _ |a GRK 2158 - GRK 2158: Naturstoffe und Analoga gegen Therapie-resistente Tumoren und Mikroorganismen: Neue Leitstrukturen und Wirkmechanismen (270650915)
|0 G:(GEPRIS)270650915
|c 270650915
|x 2
588 _ _ |a Dataset connected to CrossRef, Journals: juser.fz-juelich.de
700 1 _ |a Kreins, Alexandra Y.
|0 P:(DE-HGF)0
|b 1
700 1 _ |a Catak, Mehmet Cihangir
|0 P:(DE-HGF)0
|b 2
700 1 _ |a Babayeva, Royala
|0 P:(DE-HGF)0
|b 3
700 1 _ |a Erman, Baran
|0 P:(DE-HGF)0
|b 4
700 1 _ |a Kenney, Heather
|0 P:(DE-HGF)0
|b 5
700 1 _ |a Gungor, Hatice Eke
|0 P:(DE-HGF)0
|b 6
700 1 _ |a Cea, Pablo A.
|0 P:(DE-HGF)0
|b 7
700 1 _ |a Kawai, Tomoki
|0 P:(DE-HGF)0
|b 8
700 1 _ |a Bosticardo, Marita
|0 P:(DE-HGF)0
|b 9
700 1 _ |a Delmonte, Ottavia Maria
|0 P:(DE-HGF)0
|b 10
700 1 _ |a Adams, Stuart
|0 P:(DE-HGF)0
|b 11
700 1 _ |a Fan, Yu-Tong
|0 P:(DE-HGF)0
|b 12
700 1 _ |a Pala, Francesca
|0 P:(DE-HGF)0
|b 13
700 1 _ |a Turkyilmaz, Ayberk
|0 P:(DE-HGF)0
|b 14
700 1 _ |a Howley, Evey
|0 P:(DE-HGF)0
|b 15
700 1 _ |a Worth, Austen
|0 P:(DE-HGF)0
|b 16
700 1 _ |a Kot, Hakan
|0 P:(DE-HGF)0
|b 17
700 1 _ |a Sefer, Asena Pinar
|0 P:(DE-HGF)0
|b 18
700 1 _ |a Kara, Altan
|0 P:(DE-HGF)0
|b 19
700 1 _ |a Bulutoglu, Alper
|0 P:(DE-HGF)0
|b 20
700 1 _ |a Eltan, Sevgi Bilgic
|0 P:(DE-HGF)0
|b 21
700 1 _ |a Altunbas, Melek Yorgun
|0 P:(DE-HGF)0
|b 22
700 1 _ |a Bayram, Feyza
|0 P:(DE-HGF)0
|b 23
700 1 _ |a Karakus, Ibrahim Serhat
|0 P:(DE-HGF)0
|b 24
700 1 _ |a Karatay, Emrah
|0 P:(DE-HGF)0
|b 25
700 1 _ |a Tekeoglu, Sidem Didar
|0 P:(DE-HGF)0
|b 26
700 1 _ |a Eser, Metin
|0 P:(DE-HGF)0
|b 27
700 1 _ |a Albayrak, Davut
|0 P:(DE-HGF)0
|b 28
700 1 _ |a Citli, Senol
|0 P:(DE-HGF)0
|b 29
700 1 _ |a Kiykim, Ayca
|0 P:(DE-HGF)0
|b 30
700 1 _ |a Karakoc-Aydiner, Elif
|0 P:(DE-HGF)0
|b 31
700 1 _ |a Ozen, Ahmet
|0 P:(DE-HGF)0
|b 32
700 1 _ |a Ghosh, Sujal
|0 P:(DE-HGF)0
|b 33
700 1 _ |a Gohlke, Holger
|0 P:(DE-Juel1)172663
|b 34
|u fzj
700 1 _ |a Orhan, Fazil
|0 P:(DE-HGF)0
|b 35
700 1 _ |a Notarangelo, Luigi D.
|0 P:(DE-HGF)0
|b 36
700 1 _ |a Davies, E. Graham
|0 P:(DE-HGF)0
|b 37
700 1 _ |a Baris, Safa
|0 P:(DE-HGF)0
|b 38
|e Corresponding author
773 _ _ |a 10.1016/j.clim.2023.109757
|g p. 109757 -
|0 PERI:(DE-600)1462862-4
|p 109757
|t Clinical immunology
|v 255
|y 2023
|x 1521-6616
856 4 _ |u https://juser.fz-juelich.de/record/1014969/files/1-s2.0-S152166162300520X-main.pdf
|y OpenAccess
909 C O |o oai:juser.fz-juelich.de:1014969
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 34
|6 P:(DE-Juel1)172663
913 1 _ |a DE-HGF
|b Key Technologies
|l Engineering Digital Futures – Supercomputing, Data Management and Information Security for Knowledge and Action
|1 G:(DE-HGF)POF4-510
|0 G:(DE-HGF)POF4-511
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-500
|4 G:(DE-HGF)POF
|v Enabling Computational- & Data-Intensive Science and Engineering
|9 G:(DE-HGF)POF4-5111
|x 0
913 1 _ |a DE-HGF
|b Forschungsbereich Erde und Umwelt
|l Erde im Wandel – Unsere Zukunft nachhaltig gestalten
|1 G:(DE-HGF)POF4-210
|0 G:(DE-HGF)POF4-217
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-200
|4 G:(DE-HGF)POF
|v Für eine nachhaltige Bio-Ökonomie – von Ressourcen zu Produkten
|9 G:(DE-HGF)POF4-2171
|x 1
914 1 _ |y 2023
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2023-03-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2023-03-30
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2023-03-30
915 _ _ |a Creative Commons Attribution CC BY 4.0
|0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2023-08-23
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-08-23
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-08-23
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-08-23
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2023-08-23
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-08-23
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2023-08-23
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2023-08-23
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CLIN IMMUNOL : 2022
|d 2023-08-23
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2023-08-23
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2023-08-23
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b CLIN IMMUNOL : 2022
|d 2023-08-23
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)IBG-4-20200403
|k IBG-4
|l Bioinformatik
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-Juel1)IBG-4-20200403
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21